Patents on Mannatech's glyconutrient blend have already been issued in the
United States, Taiwan ,
Australia , Hong Kong , New Zealand , the European Union, Mexico , Singapore ,
South Africa , and Taiwan . Mannatech products can play an integral role in
wellness programs and a complementary role in traditional medicine.
Spring-boarding from first year sales of $8 million, Mannatech has now
exceeded 1.2 billion in cumulative sales with operations in the United States,
Canada, Australia, New Zealand, the United Kingdom, Japan and Korea. Mannatech
products, which support cell-to-cell communication and the immune system, have
the potential to help people maintain optimal health.
In 2003 alone, the publicly traded stock rose from $1.62 to $14.30. That is a
883% increase. This alone is a clear indication that the market sees the power
in the company's patented technology.
Mannatech has a state-of-the-art research laboratory. They partner with academia
in training doctoral and postdoctoral students. Major universities conduct and
publish clinical trials using their products.
Mannatech has more original science (not borrowed or shared science) to back up
its products than all of its competitors combined. This is a verified fact!
The science behind the patented products is so solid, the company has created an
award winning web site devoted solely to it - www.glycoscience.org.
